Mixing your own tirzepatide: the evidence and the risks

What the clinical trials used, and why that matters

Every piece of trial data that convinced regulators to license tirzepatide for weight management came from studies using Eli Lilly's proprietary formulation: a sterile, pre-filled pen with a fixed, measured dose. SURMOUNT-1, the pivotal phase-3 trial published in the New England Journal of Medicine, enrolled 2,539 adults and reported average body-weight reductions of around 20–21% at the highest dose over 72 weeks. Those results are frequently cited as the case for tirzepatide. What is less often noted is that the trial used a formulation with tightly controlled sterility, pH, excipient composition and dose accuracy, none of which can be replicated in a home mixing process. When you read our guide to mixing tirzepatide, which walks through reconstituting peptide powder with bacteriostatic water, you are reading about a preparation that was never tested in those outcome studies. The safety and effectiveness data simply do not transfer.

This distinction matters practically, not just technically. A dose that is slightly too high can intensify side effects. A preparation that is not sterile can cause infection at the injection site, or worse. The pen that arrives in Eli Lilly's licensed supply chain has been manufactured and tested to pharmaceutical standards; a powder ordered online has not.

What 'peptide mixing' actually involves, and the specific risks

Pages dedicated to tirzepatide mixing and dosing often describe reconstituting lyophilised (freeze-dried) tirzepatide powder with bacteriostatic water, drawing the result into insulin syringes and calculating doses by volume. The appeal is that powder form can be cheaper and does not require a prescription. That last point is the core problem, not an incidental one.

The risks stack up quickly. Accurate dosing requires knowing the exact concentration of peptide in the vial, and our tirzepatide mixing chart shows just how much that calculation depends entirely on trusting an unverified supplier's label. Contamination during reconstitution can introduce bacteria or particulates. Bacteriostatic water itself is a pharmaceutical product with its own storage requirements. And the person doing the mixing has no trained pharmacist checking their preparation, no prescriber reviewing their weight and health history, and no regulated clinical record if something goes wrong.

The MHRA's ongoing enforcement action illustrates the scale of the problem. Roughly 20 million doses of illegally traded weight-loss injectables, worth around £45 million, were seized in 2025 alone. In October 2025, the first illicit UK site manufacturing counterfeit tirzepatide pens was raided. Some fake pens have been found to contain insulin rather than the stated medicine. The unlicensed peptide market that feeds home-mixing guides sits in the same unregulated space.

How licensed tirzepatide actually reaches you through a regulated pharmacy

Through a GPhC-registered pharmacy, tirzepatide is dispensed as Mounjaro, the licensed UK brand, sourced through Eli Lilly's authorised supply chain. You can read about how Mounjaro works and what to expect on the Mounjaro page. The NHS's tirzepatide patient information describes the pre-filled KwikPen: each pen contains four weeks of doses, is stored in the fridge at 2–8°C, and is injected once weekly into the abdomen, thigh or upper arm using the pen's built-in mechanism. Unlike the volumes and concentrations laid out in a tirzepatide peptide mixing chart, there is no mixing, no drawing up, no vial. The dose is set; you click the pen and inject.

At nume, once a prescriber has reviewed your consultation (a real clinician, not software, reading your answers the same day) your prescription is dispensed by our GPhC-registered pharmacy and sent out via DPD tracked delivery in plain, unbranded packaging. The pen arrives ready to use. There is nothing to prepare. For anyone weighing up cost, a transparent look at Mounjaro pricing in the UK explains what a legitimate private prescription actually includes, it is a different conversation from buying unlicensed powder.

If you have questions about starting treatment properly

The reasons people look into home mixing are usually straightforward: cost, access, or frustration with waiting lists. Those are legitimate concerns. The answer, though, is a licensed medicine from a regulated pharmacy following a clinical assessment, not a workaround that trades safety for convenience. Our clinical team, led by our clinical director, reviews every consultation personally, and common questions about the process are answered on our FAQs page. If you want to explore whether tirzepatide is clinically appropriate for you, the right starting point is a proper consultation rather than a peptide supplier. Speak to our prescribers, it is free, it is the same day, and it is the only route that puts your safety first.

If you have encountered a seller offering tirzepatide or similar injectables without requiring a prescription, report them using the MHRA's Yellow Card scheme, which handles both side-effect reports and suspect product reports. That reporting genuinely matters.